Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Company Overview - Erasca, Inc. is a clinical-stage precision oncology company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers [3] - The company aims to "erase cancer" by creating novel therapies and combination regimens that comprehensively target the RAS/MAPK pathway [3] Recent Events - Erasca announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference, scheduled for September 9, 2025, at 3:20 pm Eastern Time [1] - The company will also engage in one-on-one investor meetings during the conference [1] Accessibility of Information - A live audio webcast of the conference presentation will be available on Erasca's website, with an archived replay accessible for 30 days post-event [2]